Software Daily Summary
Software Daily Summary: What Happened on November 12, 2026
Latch Bio benchmark puts AI agents through structural-biology tasks
SecureBio also began tracking changes in models’ biological-safety scores over time.
Today in brief
Latch Bio tested AI agents on 58 structural-biology tasks involving pathogen targets. The leading standard configuration passed 43.7% of them.1 SecureBio began publishing repeated BioTIER tests, which found safety-score changes in both directions across models from four developers.2
Also worth knowing
-
L
Latch Bio tested 20 models. Fable 5.2 with Claude Code led standard configurations, with a 95% confidence interval of 32.3% to 55.1%.1
-
S
BioTIER contains 542 prompts across three biological-risk levels. SecureBio measured Gemini 3.1 Pro’s refusal score rising from 46% to 74%, while Grok 4.7’s fell from 88.5% to about 80%.2
Also published
- Why So Many Patients From Underrepresented Groups Are Never Asked to Join a Trial Applied Clinical Trials
- The hardest part of becoming an AI-first company: It’s not the technology pharmaphorum
- Whoop just launched a social network TechCrunch Biotech and Health
- Vibe-coding: Structure Lens Mac in Chem